Dallas S. Shi MD, PhD, Emily McDonald MD, Melisa Shah MD, MPH, Matthew R. Groenewold PhD, James M. Haynes MPH, Bryan R. Spencer PhD, MPH, Susan L. Stramer PhD, Leora R. Feldstein PhD, MSc, Sharon Saydah PhD, MHS, Jefferson Jones MD, MPH, Sophia K. Chiu MD, MPH, Jessica L. Rinsky PhD, MPH
{"title":"Prevalence of SARS-CoV-2 infection among US blood donors by industry, May–December 2021","authors":"Dallas S. Shi MD, PhD, Emily McDonald MD, Melisa Shah MD, MPH, Matthew R. Groenewold PhD, James M. Haynes MPH, Bryan R. Spencer PhD, MPH, Susan L. Stramer PhD, Leora R. Feldstein PhD, MSc, Sharon Saydah PhD, MHS, Jefferson Jones MD, MPH, Sophia K. Chiu MD, MPH, Jessica L. Rinsky PhD, MPH","doi":"10.1002/ajim.23552","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Work is a social determinant of health that is often overlooked. There are major work-related differences in the risk of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection and death, but there have been few analyses of infection rates across industry groups. To date, only one national assessment of SARS-CoV-2 infection prevalence by industry based on self-report has been completed. No study has looked at seroprevalence of COVID-19 by industry.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>During May–December 2021, blood donors with SARS-CoV-2 antinucleocapsid testing were sent an electronic survey about their work. Free-text industry responses were classified using the North American Industry Classification System. We estimated seroprevalence and 95% confidence intervals (CIs) of SARS-CoV-2 infection by industry.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of 57,726 donors, 7040 (12%, 95% CI: 11.9%−12.5%) had prior SARS-CoV-2 infection. Seroprevalence was highest among Accommodation & Food Services (19.3%, 95% CI: 17.1%−21.6%), Mining, Quarrying, and Oil and Gas Extraction (19.2%, 95% CI: 12.8%−27.8%), Healthcare & Social Assistance (15.6%, 95% CI: 14.9%−16.4%), and Construction (14.7%, 95% CI: 13.1%−16.3%). Seroprevalence was lowest among Management of Companies & Enterprises (6.5%, 95% CI: 3.5%−11.5%), Professional Scientific & Technical Services (8.4%, 95% CI: 7.7%−9.0%), and Information (9.9%, 95% CI: 8.5%−11.5%).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>While workers in all industries had serologic evidence of SARS-CoV-2 infection, certain sectors were disproportionately impacted. Disease surveillance systems should routinely collect work characteristics so public health and industry leaders can address health disparities using sector-specific policies.</p>\n </section>\n </div>","PeriodicalId":7873,"journal":{"name":"American journal of industrial medicine","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2023-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of industrial medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ajim.23552","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Work is a social determinant of health that is often overlooked. There are major work-related differences in the risk of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection and death, but there have been few analyses of infection rates across industry groups. To date, only one national assessment of SARS-CoV-2 infection prevalence by industry based on self-report has been completed. No study has looked at seroprevalence of COVID-19 by industry.
Methods
During May–December 2021, blood donors with SARS-CoV-2 antinucleocapsid testing were sent an electronic survey about their work. Free-text industry responses were classified using the North American Industry Classification System. We estimated seroprevalence and 95% confidence intervals (CIs) of SARS-CoV-2 infection by industry.
Results
Of 57,726 donors, 7040 (12%, 95% CI: 11.9%−12.5%) had prior SARS-CoV-2 infection. Seroprevalence was highest among Accommodation & Food Services (19.3%, 95% CI: 17.1%−21.6%), Mining, Quarrying, and Oil and Gas Extraction (19.2%, 95% CI: 12.8%−27.8%), Healthcare & Social Assistance (15.6%, 95% CI: 14.9%−16.4%), and Construction (14.7%, 95% CI: 13.1%−16.3%). Seroprevalence was lowest among Management of Companies & Enterprises (6.5%, 95% CI: 3.5%−11.5%), Professional Scientific & Technical Services (8.4%, 95% CI: 7.7%−9.0%), and Information (9.9%, 95% CI: 8.5%−11.5%).
Conclusions
While workers in all industries had serologic evidence of SARS-CoV-2 infection, certain sectors were disproportionately impacted. Disease surveillance systems should routinely collect work characteristics so public health and industry leaders can address health disparities using sector-specific policies.
期刊介绍:
American Journal of Industrial Medicine considers for publication reports of original research, review articles, instructive case reports, and analyses of policy in the fields of occupational and environmental health and safety. The Journal also accepts commentaries, book reviews and letters of comment and criticism. The goals of the journal are to advance and disseminate knowledge, promote research and foster the prevention of disease and injury. Specific topics of interest include: occupational disease; environmental disease; pesticides; cancer; occupational epidemiology; environmental epidemiology; disease surveillance systems; ergonomics; dust diseases; lead poisoning; neurotoxicology; endocrine disruptors.